It has been reported that FNDC1 can activate the cell surface receptor AGS8, regulate the intracellular distribution of vascular endothelial growth factor receptor 2 (VEGFR2), promote VEGF-A-induced vascular endothelial cell signal transduction and growth, promote tumor angiogenesis, and lead to increased tumor stage (16). This evidence concerns the gene VEGFA and neoplasm.